These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1183095)

  • 41. Renovascular disease and saralasin tests.
    Ann Intern Med; 1977 Dec; 87(6):790-1. PubMed ID: 931217
    [No Abstract]   [Full Text] [Related]  

  • 42. Renin-angiotensin system in microembolic renal hypertension.
    Koletsky S; Rivera-Velaz JM
    Arch Pathol; 1968 Jan; 85(1):1-9. PubMed ID: 4294521
    [No Abstract]   [Full Text] [Related]  

  • 43. [Angiotensin antagonists in the diagnosis and treatment of renin-dependent hypertension].
    Ganten D; Gross F
    Med Klin; 1976 Nov; 71(47):2043-50. PubMed ID: 794662
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effects of saralasin on 20 hypertensive patients (author's transl)].
    Plaza de los Reyes M; Passalacqua W; Plaza de los Reyes X; Pla C; Campino C
    Rev Med Chil; 1980 Feb; 108(2):115-20. PubMed ID: 7017869
    [No Abstract]   [Full Text] [Related]  

  • 45. [Role of a competitive antagonist of angiotensin II (saralasin) in the diagnosis and therapy of arterial hypertension].
    Mazza F; Messore T; Catzola A; Corvino A; Genovese A; Catalano M; Mercone G
    Recenti Prog Med; 1983 Apr; 74(4):415-29. PubMed ID: 6348901
    [No Abstract]   [Full Text] [Related]  

  • 46. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pathogenic mechanisms in renal hypertension].
    Pietrek J
    Pol Tyg Lek; 1972 Jul; 27(25):968-71. PubMed ID: 4339351
    [No Abstract]   [Full Text] [Related]  

  • 48. Partial correction of hypertension by angiotensin II blockade in a patient with phaeochromocytoma.
    van Hoogdalem P; Donker AJ; Brentjens JR; van der Hem GK; Oosterhuis JW
    Acta Med Scand; 1977; 201(4):395-9. PubMed ID: 15405
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rebound hypertensive after sodium nitroprusside prevented by saralasin in rats.
    Delaney TJ; Miller ED
    Anesthesiology; 1980 Feb; 52(2):154-6. PubMed ID: 7352670
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical use of angiotensin blocking agents.
    Case DB
    N Y State J Med; 1977 Nov; 77(13):2100-4. PubMed ID: 200867
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effects of (1sarcosine, 8isoleucine) angiotensin II analogue on the adrenal cortex and medullary hormones].
    Mizuno K; Haruyama K; Miura T; Ogawa S; Nakajima G
    Horumon To Rinsho; 1977 Oct; 25(10):1125-9. PubMed ID: 589811
    [No Abstract]   [Full Text] [Related]  

  • 52. [The effect of aminopeptidase on experimental renal hypertension in rats].
    Klaus D; Daum A
    Klin Wochenschr; 1966 Aug; 44(15):903-4. PubMed ID: 4296034
    [No Abstract]   [Full Text] [Related]  

  • 53. Reduction in severity of acute renal failure in rats by beta-adrenergic blockade.
    Iaina A; Solomon S; Eliahou HE
    Lancet; 1975 Jul; 2(7926):157-9. PubMed ID: 49748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renin kinetics in experimental renal hypertension.
    Lazar J; Romero JC; Hoobler SW
    Am J Physiol; 1971 Jan; 220(1):191-5. PubMed ID: 4321202
    [No Abstract]   [Full Text] [Related]  

  • 55. Renal-clip hypertension in rabbits immunized against angiotensin II.
    Macdonald GJ; Louis WJ; Renzini V; Boyd GW; Peart WS
    Circ Res; 1970 Aug; 27(2):197-211. PubMed ID: 4318416
    [No Abstract]   [Full Text] [Related]  

  • 56. Continuous angiotensin II blockade throughout the acute phase of one-kidney hypertension in the dog.
    Watkins BE; Davis JO; Freeman RH; DeForrest JM; Stephens GA
    Circ Res; 1978 Jun; 42(6):813-21. PubMed ID: 657442
    [No Abstract]   [Full Text] [Related]  

  • 57. [A review of hypertension with hypopotassemia (author's transl)].
    Koang AK
    Zhonghua Nei Ke Za Zhi; 1979; 18(1):65-70. PubMed ID: 399451
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical application of angiotensin II derivatives].
    Kono T
    Horumon To Rinsho; 1978 Aug; 26(8):751-9. PubMed ID: 688673
    [No Abstract]   [Full Text] [Related]  

  • 59. The effect of injected chloroform on renal hypertension.
    Loyke HF
    Anesth Analg; 1971; 50(5):825-8. PubMed ID: 4329748
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical applications of synthetic angiotensin II analogue.
    Ogihara T; Yamamoto T; Kumahara Y
    Jpn Circ J; 1974 Nov; 38(11):997-1003. PubMed ID: 4373592
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.